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Development of Early Nuclear Antigen in Cytomegalovirus Infected
Cells in the Presence of RNA and Protein Synthesis Inhibitors (Accepted 2 March I978) SUMMARY Human cytomegaloviruses (HCMV) induce nuclear antigens as early as I h after infection as detected by immunofluorescence. Early antigen development occurs in the presence of DNA, RNA, and protein synthesis inhibitors and is dependent on intact viral DNA in the inoculum.
Human cytomegalovirus (HMCV) has an eclipse period of 48 h in permissive human fibroblast cells and the replicative events of this long latency interval are poorly defined. Of great interest in this regard was the recent finding that HCMV-specific antigens appear in the nuclei of infected permissive cells as early as 3 h p.i. as determined by the anticomplement immunofluorescent test (ACIF; Geder, I976). During a study of the morphology and kinetics of immunofluorescent HCMV antigens in human fibroblasts in this laboratory, 'immediate' early nuclear antigen was observed by I h p.i. using the ACIF and anti-human IgG immunofluorescent (IFA) assays. This report describes the effects of DNA, RNA, and protein synthesis inhibitors on the development of this antigen and offers evidence that its production is apparently independent of virus DNA, RNA, and protein synthesis while requiring intact parental virus DNA.
Monolayers of human foreskin fibroblasts (HFF), locally obtained, were grown to confluency on Lab Tek tissue culture slides (Lab Tek Products, Naperville, Ill.) in medium I99 supplemented with 5 % heat-inactivated neonatal calf serum. The ADt69 strain of HCMV was used for the kinetic analysis of intracellular antigens at multiplicities of infection (m.o.i.) from o.o16 to 2.o p.f.u./cell. Monolayers without inhibitors were incubated with the virus inoculum for I h, after which the inoculum was removed and fresh medium added. Inhibitor treated monolayers were either pre-incubated with the compound and/or exposed to it simultaneously with the virus. Following a I h absorption, the fluid was aspirated and inhibitor containing medium was again added. Antigen development was assessed at 1, 2, 3, 4, i2 and 24 h p.i. At these intervals, slides were washed with phosphate buffered saline (pH 7"4), air dried and fixed in acetone for Io min at room temperature. Two standard laboratory strains, Davis and Towne, plus three adapted clinical isolates available in this laboratory were similarly assayed after 4 h for antigen production at a m.o.i, of o.I p.f.u./cell. As a control, the development of herpes simplex type I virus (HSV-I) antigens (m.o.i.o.2 p.f.u./cell) in HFF in the presence and absence of inhibitors was examined as above at I, 2, 3, 5 and 7 h p.i.
The IFA and ACIF assays were performed according to procedures standardized in this laboratory as described elsewhere (Stagno et al. 1975, I977) . For routine specificity control, a non-immune serum and uninfected HFF were tested in each assay.
Human sera with and without HCMV antibody (IFA against late antigen [LA]) were obtained from children with congenital CMV infection, mothers delivering congenitally infected offspring, pregnant women selected on the basis of parity and laboratory personnel. Two high titre immune sera 'I.J.' and 'W.P.' were employed as the reference positive sera for the kinetic studies (titres of Io24, 256 and ~o24 in the IFA-LA, ACIF-LA, and neutralization tests, respectively). The remaining 4o sera were. tested for reactivity against the 4 and 24 h antigen preparations only. Guinea pig antiserum to purified ADI69 virions obtained from Dr E. Huang, University of North Carolina and rabbit antiserum to ADI69 antigen prepared in this laboratory from clarified sonicates of infected (m.o.i.I.O) HFF 5 days p.i. were also assayed for antibody against the 4 and 24 h antigen preparations. Human serum 'CAP' was used as the HSV-I antigen probe (titre of 4o96 in the IFA-LA test). All sera were tested at a I : 5 dilution in phosphate-buffered saline (standard diluent) following heat inactivation (56 °C for 3o rain).
Fluorescence was limited exclusively to the nucleus during the first 4 h p.i. as assessed by either method. Homogeneous staining was detected as early as I h after infection Fig. ~ a) . By 3 to 4 h p.i. the nuclei fluoresced more intensely and 2 to 5 aggregates of fluorescence were easily visualized in most nuclei (Fig. I b) . The number of fluorescing nuclei and the intensity of the stain were grossly proportional to the multiplicity of input (see Table ~ ). An identical fluorescence pattern was observed following infection with the two additional laboratory strains as well as the three adapted clinical isolates.
Nuclear antigen at I2 h p.i. comprised larger and brighter aggregates on a homogeneous background; a few cells also displayed homogeneous cytoplasmic fluorescence. By 24 h p.i., the typical pattern consisted of bright nuclear fluorescence with distinct aggregates, diffuse cytoplasmic staining and a prominent paranuclear inclusion (Fig. I c) .
The development of early nuclear fluorescence was dependent on the presence of infectious virus. Heat inactivation (56 °C for 3o rain), neutralization with serum 'I.J. ', and u.v. irradiation (I5 min at 8 cm under a germicidal lamp) of the inoculum prevented antigen production (Table I) . Conversely, u.v. irradiation of the monolayers for Io rain prior to infection had no effect on the staining reaction.
The antigenic specificity of the early nuclear antigen for HCMV was demonstrated by the following results. Eleven non-immune sera, including seven samples from multiparous women, gave negative reactions. In contrast, the 4 and 24 h virus antigens were detected by 23 of 3I seropositive sera. The eight non-reactive sera were obtained from six children and two women with long standing infection. None of the 42 sera elicited fluorescence in uninfected cells. Furthermore, the high titre sera 'I.J.' and 'W.P.' lost their reactivity following absorptions with either 4 h or I2o h infected cells (I5 x I@ infected, m.o.i.I.o, cells mixed with I'o ml of a I : 5 dilution of serum, sonicated, and incubated for I h at 37 °C and overnight at 4 °C). An absorption with uninfected cells caused no loss in staining potency (Table I) .
To determine whether hyperimmunization of animals with HCMV resulted in the production of antibody to this early nuclear antigen, two different animal antisera were assayed for reactivity against the 4 and 24 h preparations by the ACIF procedure. The hyperimmune rabbit serum raised against late intracellular virus antigens produced fluorescence in both preparations which was indistinguishable from that seen with human immune serum. In contrast, the guinea pig antiserum against purified virions elicited a dim nuclear fluorescence in 25 % of cells, at each time interval. Neither antiserum reacted with the nuclei of uninfected cells (Table I) .
Simultaneous treatment of infected monolayers with actinomycin D 0o #g/ml), cycloheximide (IOO #g/ml), puromycin (5o #g/ml) or ara-C (25 #g/ml) failed to abolish immediate nuclear antigen development as did a 3 h pre-incubation of cells with these ? Multiplicity of infection with ADI69 strain, 2'o. Number of sera reactive; range of intensity of stain, 4+ to I +.
Short communications
increasing dilutions of § Time of exposure of monolayers to inhibitor relative to virus inoculation; continuous exposure to inhibitor during virus absorption and thereafter.
LL Intensity of stain very weak. ¶ Not done.
compounds. Likewise, 4 h nuclear antigen production was unaffected by a 24 h pre-incubation with fibroblast interferon (too international units/ml -a concentration which reduced plaque formation by 95 %). Similar results were obtained with the Davis strain. The pattern of fluorescence was identical to control infected cells in the presence of all the inhibitors except actinomycin D which prevented the appearance of aggregates within the nucleus. In a separate morphological experiment using Turks stain (basic dye in acid medium) on actinomycin D-treated and untreated HFF monolayers, the drug was observed to cause the disappearance of nucleoli in the treated HFF cells -an injury previously described by others (Schoefl, I964) . The continued presence of the compounds on the cells throughout 24 h p.i. lead to an arrest of the fluorescence pattern at the 4 h stage with actinomycin D, cycloheximide and puromycin. The intensity of the stain, however, was less than that observed in the 4 h preparation (Fig. I d and e) . In the interferon pro-treated monolayers m.o.i, o'5 p.f.u./cell), 5 ° % of infected cells showed this early arrest while the remainder displayed a typical 24 h fluorescence pattern. Ara-C-treated infected cells had a fluorescence pattern at 24 h p.i. which was indistinguishable from the control.
Pro-treatment of HFF monolayers for 2 4 h prior to infection with cycloheximide (20 /~g/ml) virtually eliminated staining of infected nuclei at 4 h p.i. whereas similar proincubations with actinomycin D (Io/~g and 2 #g/ml) and ara-C (2 5 #g/ml) had n3 such effect. Neither cell toxicity nor prevention of penetration seem likely causes of this attenuation since trypan blue exclusion, cell growth and the ability to produce infectious virus following cycloheximide pre-incubation was similar to untreated cells. The effect of the various inhibitor treatments on early nuclear antigen production is summarized in Table I .
In contrast to HCMV antigen development, HSV-I induced nuclear fluorescence, first noted at 2 h p.i., was completely abolished by simultaneous treatment with similar concentrations of RNA and protein synthesis inhibitors. These findings establish the biological activity of the inhibitors and in addition document that this antigen is not common to all members of the herpesvirus group.
Further evidence for the functional activity of the cycloheximide was obtained by measuring the incorporation of tritiated leucine over 3 h (7 #Ci in leucine-free medium I99 per 5 x I@ HFF cells following actual or mock infection) into protein in the presence or absence of 1oo #g/ml of the inhibitor. The radioactivity of newly synthesized protein was measured in a liquid scintillation counter following sonication of the cells, SDS (o.I %) and TCA (IO%) extraction, and harvesting of the precipitates on to o'45/zm filters by a vacuum pump. In infected (m.o.i. I "o) monolayers, cycloheximide reduced protein synthesis by 97"I % from 398ooo to I35OO ct/min. A similar degree of suppression, 97"4%, was observed in uninfected monolayers, i.e. 433 ooo to I 1 300 ct/min. These data represent a unique finding that a human DNA virus is capable of inducing virus specific antigen in the nuclei of permissive cells in the presence of potent inhibitors of RNA and protein synthesis. The exact nature of this unusual antigen is enigmatic but several characteristics are noteworthy. Its development is dependent on the presence of intact parental virus DNA in the inoculum. A role for pro-formed host cell protein is suggested, though not absolutely proven, by the attenuation effect seen with a z 4 h proincubation with cycloheximide. That the antigen is composed exclusively of parental structural virus components is unlikely, based on the lack of induction when the inoculum is u.v.-irradiated-a procedure that does not prevent penetration (Albrecht et al. I974) . Persistence of the antigen or, conversely, antigenic cross reaction with late virus products is suggested by the observation that its specific antibody is absorbed out by late virus intracellular antigen. Further, immunization of rabbits with late virus antigen resulted in the production of substantial amounts of antibody with early nuclear antigen specificity. In contrast, immunization of guinea pigs with purified virions elicited far less antibody against this antigen, again suggesting that structural virion components are not, in fact, the antigen per so.
The function of this immediate early nuclear antigen is of interest. Human CMV has been shown to stimulate host cell RNA and DNA synthesis in both homologous and
